跳至主要内容
临床试验/CTRI/2023/07/055597
CTRI/2023/07/055597尚未招募2 期

Pattern of response and toxicity in case of dose escalated intensity-modulated radiotherapy in the treatment of loco-regionally advanced carcinoma cervix -a prospective study - Nil

Dr Anjan Bera0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age- 30 to 70 years
  • Histologically confirmed non-metastatic loco-regionally advanced carcinoma of the cervix (FIGO Stage- IIB-IVA
  • Adequate hematological functions
  • Adequate hepatic, renal function, and cardiac evaluation
  • ECOG performance status 0-3
  • Participants can understand and sign informed Consent for the study

排除标准

  • Any medical condition that precludes delivery of Radiation Therapy/ Concurrent Chemotherapy
  • Metastatic Cervical carcinoma
  • Patients unable to answer or unable to provide subjective information.

研究者

发起方
Dr Anjan Bera

相似试验

进行中(未招募)
不适用
An evaluation of the dose-response relationship of Cizolirtine citrate 300 mg, twice daily, and 400 mg, twice daily, versus placebo in subjects with urge urinary incontinence.A 12-week, randomised, double-blind, placebo-controlled, multicentre study, parallel-group, Phase III clinical study with a 12 months safety follow-up period.rge Urinary Incontinence
EUCTR2004-001119-69-ESaboratorios Dr. Esteve, SA450
进行中(未招募)
1 期
An evaluation of the dose-response relationship of Cizolirtine citrate 300 mg, twice daily, and 400 mg, twice daily, versus placebo in subjects with urge urinary incontinence.A 12-week, randomised, double-blind, placebo-controlled, multicentre study, parallel-group, Phase III clinical study with a 12 months safety follow-up period.rge Urinary Incontinence
EUCTR2004-001119-69-CZaboratorios Dr. Esteve, SA450
进行中(未招募)
1 期
Investigation of dose response relationships when using low dose naltrexone (LDN) for the treatment of fibromyalgiaFibromyalgiaMedDRA version: 20.0Level: LLTClassification code 10016631Term: Fibromyalgia syndromeSystem Organ Class: 100000004859
EUCTR2016-002081-31-DKAnæstesiologisk-intensiv afd V, Odense Universitets Hospital38
已完成
不适用
A study to evaluate the dose-response effect of tolvaptan 7.5mg or 15mg in HF patients who undergo cartdiac angiographyHeart Failure
JPRN-UMIN000009924Showa University Northern Hospital100
尚未招募
Unknown
Acute reactions and dosimetry associated with old and new adjuvant radiation in carcinoma breast
CTRI/2024/07/071736Dr.Harikrishna Suresh